Cargando…
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
The development of cancer therapies is limited by the availability of suitable drug targets. Potential candidate drug targets can be identified based on the concept of synthetic lethality (SL), which refers to pairs of genes for which an aberration in either gene alone is non-lethal, but co-occurren...
Autores principales: | Srivatsa, Sumana, Montazeri, Hesam, Bianco, Gaia, Coto-Llerena, Mairene, Marinucci, Mattia, Ng, Charlotte K. Y., Piscuoglio, Salvatore, Beerenwinkel, Niko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751287/ https://www.ncbi.nlm.nih.gov/pubmed/36517508 http://dx.doi.org/10.1038/s41467-022-35378-z |
Ejemplares similares
-
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens
por: Montazeri, Hesam, et al.
Publicado: (2021) -
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
por: Bianco, Gaia, et al.
Publicado: (2022) -
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
por: Bianco, Gaia, et al.
Publicado: (2022) -
Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens
por: Karimpour, Mina, et al.
Publicado: (2023) -
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues
por: Marinucci, Mattia, et al.
Publicado: (2022)